Pharma Pulse: What the USMCA Joint Review Means for Pharma

Jun 24, 03:22 PM
Headliner
Share
Subscribe
In this special episode of Pharma Pulse, Rohit Tripathi breaks down how companies should be scenario planning now, ahead of the first USMCA joint review which begins on July 1.
Share
Subscribe
Next
Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse